Alcon plans to integrate the newly acquired ocular surgical guidance technology into its existing global cataract portfolio, and leverage its global leadership in eye care to help bring this advanced technology to surgeons across the world. Alcon offers the industry’s most complete line of surgical products for cataract surgery, including equipment for cataract procedures, as well as IOLs to treat cataracts and correct refractive errors, like presbyopia and astigmatism.
“We are proud and glad to have found in Alcon the best possible business partner to develop the potential of our team, technology, and products in cataract surgery”, said the former head of the SMI Ophthalmic Division Dr. Oliver Kersting who continues at Alcon to lead the integration of the SMI technology into Alcon’s cataract product portfolio. “We know and have been working with Alcon successfully for more than a decade. We have great respect for Alcon’s leadership in Ophthalmology and their ability to bring innovations to broad market.” said Eberhard Schmidt, Managing Director of SMI. “SMI has been growing very rapidly and faces a dramatically expanding array of opportunities based on our leading technology platform. Multimodal user interaction as well as analytical applications provide great opportunities to bring valuable innovations to scientists, OEM-Partners and end-users that will benefit from our increased focus in this area going forward.”